In yesterday’s Wall Street session, Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shares traded at $1.40, down -11.95% from the previous session.
9 analysts cover Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $4.00 and a low of $0.85, we find $1.25. Given the previous closing price of $1.59, this indicates a potential downside of -21.38 percent. AVAH stock price is now 23.06% away from the 50-day moving average and -14.75% away from the 200-day moving average. The market capitalization of the company currently stands at $224.39M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
The stock has received a hold rating from 5 analysts and a buy rating from 2. Brokers who have rated the stock have averaged $1.91 as their price target over the next twelve months.
With the price target reduced from $2 to $1, Credit Suisse Downgraded its rating from Neutral to Underperform for Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH). On November 21, 2022, RBC Capital Mkts Downgraded its previous ‘Outperform’ rating to ‘Sector Perform’ on the stock reducing its target price from $7 to quote $3, while ‘Credit Suisse’ rates the stock as ‘Neutral’.
In other news, Afshar David, Chief Financial Officer bought 10,000 shares of the company’s stock on Aug 24. The stock was bought for $20,140 at an average price of $2.01. Upon completion of the transaction, the Chief Financial Officer now directly owns 288,240 shares in the company, valued at $0.4 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 26, Chief Compliance Officer Cunningham Patrick A. bought 3,100 shares of the business’s stock. A total of $9,626 was incurred on buying the stock at an average price of $3.10. This leaves the insider owning 122,195 shares of the company worth $0.17 million. A total of 0.40% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AVAH stock. A new stake in Aveanna Healthcare Holdings Inc. shares was purchased by KING STREET CAPITAL MANAGEMENT, L.P. during the first quarter worth $879,000. CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. invested $114,000 in shares of AVAH during the first quarter. In the first quarter, WIPFLI FINANCIAL ADVISORS LLC, acquired a new stake in Aveanna Healthcare Holdings Inc. valued at approximately $81,000. Y-INTERCEPT (HONG KONG) LTD acquired a new stake in AVAH for approximately $75,000. CREATIVE PLANNING purchased a new stake in AVAH valued at around $56,000 in the second quarter. In total, there are 128 active investors with 92.30% ownership of the company’s stock.
On Thursday morning Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) stock kicked off with the opening price of $1.5400. During the past 12 months, Aveanna Healthcare Holdings Inc. has had a low of $0.67 and a high of $6.00. As of last week, the company has a debt-to-equity ratio of 6.22, a current ratio of 0.90, and a quick ratio of 0.90. The fifty day moving average price for AVAH is $1.1377 and a two-hundred day moving average price translates $1.6421 for the stock.
The latest earnings results from Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) was released for Sep, 2022. According to the Medical Care Facilities Company, earnings per share came in at -$0.03, missing analysts’ expectations of $0.03 by -0.06. This compares to $0.01 EPS in the same period last year. The net profit margin was -31.40% and return on equity was -126.70% for AVAH. The company reported revenue of $443.01 million for the quarter, compared to $411.28 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.72 percent. For the current quarter, analysts expect AVAH to generate $448.16M in revenue.
Aveanna Healthcare Holdings Inc.(AVAH) Company Profile
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
